Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EXPAREL for postsurgical pain in lumbar spine surgery
NCT03927911Phase 4Terminated
- Sponsor
- Pacira BioSciences
- Start
- Jul 2019
- Primary completion
- Aug 2020
- Countries
- 1
01
Overview
Phase 4, open-label trial of liposomal bupivacaine in postoperative pain (6 cohorts), sponsored by Pacira BioSciences. Primary endpoint: Post-surgical Opioid Consumption in mg oral morphine equivalent dosing at 72 hours. Started Jul 2019; status: terminated.
02
Drugs
liposomal bupivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT03927911.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03927911.